Our Research
Allogeneic umbilical cord blood mononuclear cell therapyfor spinal cord injury – a retrospective cohort study
Previous studies have reported that human umbilical cord blood-derived stem cell therapy is safe and effective for subjects with Spinal Cord Injury (SCI). The objective of this retrospective cohort study was to analyze the muscle, nerve, urinary, and gastrointestinal function in subjects with SCI, treated with either human umbilical cord blood-derived mononuclear cells (hUCMNCs) or conventional therapy.
B. M. Mehling, D.-C. Wu, L. Quartararo, S. J. Roman, A. S. Pickoff, A. Stolfi, B. Szelestey, R. Rutherford, M. Manvelyan